Skip to main content

Table 1 The demographic, clinical and biochemical characteristics of controls and patients

From: Correlation of trans fatty acids with the severity of coronary artery disease lesions

Variables Controls
n = 120
CAD group
n = 111
Age (years) 57.10 ± 12.65 60.83 ± 90**
Current smoking n (%) 14 (12) 38 (34)**
Diabetes n (%) 0 (0) 43 (39)**
High blood pressure n (%) 0 (0) 52 (47)**
Hyperlipidemia n (%) 0 (0) 50 (45)**
BMI (kg/m2) 27.73 ± 3.43 29.44 ± 4.28*
Obesity n (%) 0 (0) 46 (41)**
Menopause n (%) 26 (22) 28 (25)
Family history n (%) 0 (0) 24 (22)**
Gensini score 28 (13, 52)**
Total cholesterol (mmol/L) 4.80 ± 0.78 4.97 ± 0.99
LDL-C (mmol/L) 3.10 ± 0.81 3.11 ± 0.92
HDL-C (mmol/L) 1.22 ± 0.44 1.01 ± 0.24**
Triglycerides (mmol/L) 1.33 ± 0.38 1.83 ± 0.86**
Hemoglobin A1c (%) 5.24 ± 0.92 8.61 ± 3.06**
Glucose (mmol/L) 5.10 ± 0.80 9.62 ± 4.70**
ApoA1 (g/L) 1.30 ± 0.15 1.12 ± 0.17**
APoB (g/L) 0.60 ± 0.14 0.77 ± 0.24**
Total cholesterol /HDL 4.31 ± 1.45 5.19 ± 1.76**
Triglycerides /HDL 1.23 ± 0.57 1.96 ± 1.09**
LDL/HDL 2.87 ± 1.30 3.30 ± 1.48*
ApoB/ApoA1 0.47 ± 0.13 0.70 ± 0.21**
  1. Data are expressed as n (%) (number of persons, (percent)), mean ± SD (standard deviation) or median (interquartile, range)
  2. CAD coronary artery disease, BMI body mass index, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, ApoA1 Apolipoprotein A1, ApoB Apolipoprotein B
  3. A significant difference between controls and coronary artery disease patients is indicated by *(Mann Whitney Test). *: p < 0.05. A significant difference between controls and patients (CAD group) is indicated by *(p < 0.05) or **(p < 0.001)